MSD antibiotic patent obvious, says Federal Circuit

27-10-2017

MSD antibiotic patent obvious, says Federal Circuit

artisteer / iStockphoto.com

Merck Sharp & Dohme (MSD) has suffered a loss at the US Court of Appeals for the Federal Circuit, after the court affirmed an earlier finding of obviousness.


Merck Sharp & Dohme, patent, Hospira, US Court of Appeals for the Federal Circuit, obviousness,

LSIPR